Single Ventricle Heart Disease clinical trials at UCSF

1 research study open to eligible people

Single ventricle heart disease is a rare condition where one pumping chamber supports circulation. UCSF is conducting clinical research that measures exercise, breathing, and heart responses. One study compares an oral drug, udenafil, to placebo to monitor safety and exercise changes.

Showing trials for

  • Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

    open to eligible people ages 12-18

    This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent who have had the Fontan procedure.

    San Francisco, California and other locations

Our lead scientists for Single Ventricle Heart Disease research studies include .

Last updated: